Frontiers in Oncology | Thoracic Oncology

Systematic Review

Published on 09 Jan 2024

Primary pulmonary nuclear protein of the testis midline carcinoma: case report and systematic review with pooled analysis

in Thoracic Oncology

Dong Zhao
Wei Cao
Shiqian Zha
Yixuan Wang
Zhou Pan
Jingyi Zhang
Ke Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1308432

1,702 views

Original Research

Published on 09 Jan 2024

Molecular epidemiology study of programmed death ligand 1 and ligand 2 protein expression assessed by immunohistochemistry in extensive-stage small-cell lung cancer

in Thoracic Oncology

Torben Steiniche
Jeanette Baehr Georgsen
Peter Meldgaard
Anne C. Deitz
Mark Ayers
M. Catherine Pietanza
Ke Zu

Frontiers in Oncology

doi 10.3389/fonc.2023.1225820

1,425 views

Original Research

Published on 08 Jan 2024

Characterizing the secretome of EGFR mutant lung adenocarcinoma

in Thoracic Oncology

Jennifer K. Luu
Fraser D. Johnson
Jana Jajarmi
Tianna Sihota
Rocky Shi
Daniel Lu
Dylan Farnsworth
Sandra E. Spencer
Gian Luca Negri
Gregg B. Morin

Frontiers in Oncology

doi 10.3389/fonc.2023.1286821

2,465 views
1 citation

Original Research

Published on 08 Jan 2024

Incidence of venous thromboembolism and association with PD-L1 expression in advanced non-small cell lung cancer patients treated with first-line chemo-immunotherapy

in Thoracic Oncology

Liliana Aguiar De Azevedo
Charles Orione
Cécile Tromeur
Francis Couturaud
Renaud Descourt
Margaux Geier

Frontiers in Oncology

doi 10.3389/fonc.2023.1221106

1,858 views
3 citations

Mini Review

Published on 08 Jan 2024

Vats lobectomy for lung cancer. What has been the evolution over the time?

in Thoracic Oncology

Emanuela Re Cecconi
Giuseppe Mangiameli
Matilde De Simone
Ugo Cioffi
Giuseppe Marulli
Alberto Testori

Frontiers in Oncology

doi 10.3389/fonc.2023.1268362

2,405 views
9 citations

Editorial

Published on 05 Jan 2024

Editorial: World lung cancer awareness month 2022: artificial intelligence for clinical management of lung cancer

in Thoracic Oncology

Parul Agarwal
Yanhui Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1351016

1,474 views
1 citation

Perspective

Published on 22 Dec 2023

Treating patients with platinum-sensitive extensive-stage small-cell lung cancer in a real-world setting

in Thoracic Oncology

Jacob Sands
Janakiraman Subramanian

Frontiers in Oncology

doi 10.3389/fonc.2023.1161931

5,053 views
1 citation

Original Research

Published on 19 Dec 2023

Clinical and molecular profiling of EGFR-mutant lung adenocarcinomas transformation to small cell lung cancer during TKI treatment

in Thoracic Oncology

Yongxia Chen
Mengye He
Zhengfeng Dai
Yina Wang
Jing Chen
Xiaoting Wang
Xiao Dong
Jianfei Huang
Jian Ruan
Xiaochen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1308313

2,293 views
5 citations

Correction

Published on 19 Dec 2023

Corrigendum: The presence of autoantibodies is associated with improved overall survival in lung cancer patients

in Thoracic Oncology

Keying Jing
Huijuan Zhao
Jun Cai
Lianlian Chen
Peiming Zheng
Libo Ouyang
Gang Li
Rong Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1353702

641 views

Review

Published on 19 Dec 2023

Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer

in Thoracic Oncology

Yanting Wang
Tao Zhang
Xin He

Frontiers in Oncology

doi 10.3389/fonc.2023.1279822

2,543 views
7 citations

Original Research

Published on 13 Dec 2023

TICRR serves as a prognostic biomarker in lung adenocarcinoma with implications in RNA epigenetic modification, DDR pathway, and RNA metabolism

in Thoracic Oncology

Xunbo Zheng
Li Han
Jun Guan
Chenteng Chen
Yue Zhang
Jiali Zhang
Yiran Zhang
Siyao Liu
Junyan Su
Mengyuan Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1274439

3,026 views
1 citation

Review

Published on 11 Dec 2023

AI/ML advances in non-small cell lung cancer biomarker discovery

in Thoracic Oncology

Minal Çalışkan
Koichi Tazaki

Frontiers in Oncology

doi 10.3389/fonc.2023.1260374

4,084 views
7 citations

Review

Published on 08 Dec 2023

Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges

in Thoracic Oncology

Sukumar Kalvapudi
Yeshwanth Vedire
Sai Yendamuri
Joseph Barbi

Frontiers in Oncology

doi 10.3389/fonc.2023.1286104

6,934 views
6 citations

Case Report

Published on 06 Dec 2023

High-grade fetal adenocarcinoma of the lung misdiagnosed as male breast carcinoma: a case report and literature review

in Thoracic Oncology

Yuejian Zhuo
Yanran Xu
Rong Qin
Min Guo
Dongdong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1293534

1,434 views

Original Research

Published on 06 Dec 2023

Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, Canada

in Thoracic Oncology

David E. Dawe
Rebekah Rittberg
Iqra Syed
Mary Kate Shanahan
Daniel Moldaver
Oliver Bucher
Katie Galloway
Kayla Reynolds
James T. Paul
Craig Harlos

Frontiers in Oncology

doi 10.3389/fonc.2023.1191920

2,575 views
1 citation

Review

Published on 05 Dec 2023

Recent advances progress of targeted drugs combined with radiotherapy for advanced non-small cell lung cancer: a review

in Thoracic Oncology

Jiamin Xu
Zhongming Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1285593

2,110 views